Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This funding opportunity invites applications for Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers, which are categorized into three types: Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Cancer Centers. Comprehensive Centers demonstrate strong research activity in basic laboratory, clinical, and prevention/control research while fostering transdisciplinary collaboration. Clinical Cancer Centers primarily focus on some combination of these areas without the broader scope of Comprehensive Centers, while Basic Cancer Centers specialize exclusively in basic laboratory research. The grants aim to consolidate institutional cancer research capabilities into a unified, interdisciplinary research enterprise that crosses institutional boundaries. Supported Cancer Centers are expected to be key contributors to advancing knowledge about cancer and developing improved methods for prevention, diagnosis, and treatment. Additionally, they must develop Shared Resources to facilitate research, collaborate with other NCI-funded programs and researchers, and actively disseminate their findings to benefit the wider community. The grant application process is managed by the National Cancer Institute under the Department of Health and Human Services, and the opportunity was announced in March 2026. Applicants can seek further information via the Office of Cancer Centers at NCI.

General Info

Funding supports NCI-Designated Cancer Centers to advance interdisciplinary cancer research and collaboration.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

813212 - Voluntary Health OrganizationsView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUSA
Contacts
Office of Cancer Centers National Cancer Institute (NCI
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Clinical Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas, and 3) Basic Cancer Centers, which focus on basic laboratory research. The purpose of all types of NCI-Designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this NOFO are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of Shared Resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.

Similar Contracts

Same NAICS industry code

NAICS: 813212
Grant
Drug-Free Communities (DFC) Support Program – Competing Continuation (Year 6)The Drug-Free Communities (DFC) Support Program, administered by the CDC's National Center for Injury Prevention and Control and the ONDCP, is seeking applications for Fiscal Year 2026 grants. The program aims to establish and strengthen collaborations between public and private non-profit agencies and various levels of government to support community coalitions focused on preventing and reducing substance use among youth aged 18 and younger. A primary objective is to address community risk factors while promoting protective factors to decrease substance use among youth and eventually adults. This specific funding opportunity is designated as a competing continuation for Year 6 and is intended for applicants who have either completed their initial five-year funding cycle or have experienced a lapse in funding. The forecast is associated with NAICS code 813212 and is managed by the Department of Health and Human Services. Interested parties can contact Christi Jones for further information regarding the application process.
Centers For Disease Control - Ncipc

POSTED

17 days ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and ProvidersThis funding opportunity aims to advance the Centers for Disease Control and Prevention’s goals for combating viral hepatitis by strengthening community and provider-level responses to hepatitis B and C in populations most affected. It is structured into two distinct components: Part A focuses on building and sustaining a coalition of public and private organizations to expand educational outreach, increase testing capacity, and improve linkage to care for disproportionately impacted communities through technical assistance and training. Part B targets healthcare professionals by providing free, on-demand, web-based educational resources with continuing education credits and actively promoting these tools to enhance clinical competence in hepatitis B and C evaluation and treatment. Both components work in tandem to empower populations to make informed health decisions and ensure timely access to care, ultimately reducing illness and death from viral hepatitis. Applications for each part must be submitted separately, allowing organizations to pursue one or both components based on their capacity and focus. The initiative is managed by the CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention under the Department of Health and Human Services, with point of contact provided for inquiries.
Centers For Disease Control - Nchhstp

POSTED

about 1 month ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
2026 Alaska Marine Education and Training Mini-Grant Program
Solicitation # NOAA-NMFS-AK-2026-33268
The 2026 Alaska Marine Education and Training Mini-Grant Program, under solicitation NOAA-NMFS-AK-2026-33268, is a federal financial assistance opportunity administered by NOAA’s National Marine Fisheries Service to advance workforce development, technological innovation, and supply chain resilience in Alaska’s marine and seafood sectors. Projects must be conducted entirely within Alaska and align with Executive Order 14276, focusing on training for marine science, aquaculture, and maritime operations; improving seafood safety and management practices; promoting consumer education on sustainable seafood; integrating local knowledge into regional fishery management; and fostering partnerships among industry, researchers, and community organizations. The program offers individual awards ranging from $15,000 to $75,000, with a total of $600,000 available over three years, subject to annual congressional appropriation. Applicants must submit a complete application package through Grants.gov, including required federal forms, a five-page project narrative, a two-page budget narrative, and supporting attachments not exceeding ten pages in total, all compiled into a single flattened PDF under 100 MB. Proposals are evaluated on a 75-point scale, with the highest weight given to Technical/Scientific Merit and Overall Qualifications of Applicants, each worth 25 points, followed by Outreach and Education (15 points) and Project Costs (10 points). Awards are made through a merit-based trade-off process, not based on lowest price, and may consider geographic balance, program priorities, and prior performance. Key requirements include registration in SAM.gov with a valid Unique Entity Identifier, compliance with 2 CFR Part 200, adherence to NOAA’s Scientific Integrity Policy, and submission of semi-annual performance and financial reports via eRA Commons. Recipients must also comply with FFATA reporting for subawards exceeding $30,000 and demonstrate organizational capacity to manage federal funds, report harassment incidents, and maintain transparency in all research activities. Submission deadlines occur on June 22, 2026, May 3, 2027, and May 1, 2028, with project performance periods beginning no earlier than September 1 of the award year and lasting one to two years. No contract clauses, packaging, or inspection requirements from the FAR apply, as this is a grant, not a procurement, and all administrative oversight is governed by federal grant regulations.
Department Of Commerce Noaa

POSTED

4 months ago

DEADLINE

in over 1 year
View Details
NAICS: 813212
Grant
Preventing Youth Overdose: Treatment, Recovery, Education, Awareness and TrainingThis contract focuses on a program aimed at preventing youth overdose by enhancing local awareness of fentanyl risks among young people. It seeks to broaden screening and diagnosis efforts for opioid use disorder (OUD) in youth populations and improve access to medications for opioid use disorder (MOUD). The initiative also aims to provide comprehensive training for healthcare providers, families, and school personnel on effective strategies to support youth affected by OUD and those undergoing MOUD treatment. The program is administered by the Substance Abuse and Mental Health Services Administration under the Department of Health and Human Services and was posted on March 20, 2026. It includes outreach, education, treatment, recovery, and training components designed to address the opioid crisis among youth comprehensively. Contact for the program is available via Arianna Douglas, with communication details provided. The project supports multi-sector collaboration to reduce overdose risk and enhance the overall health and safety of youth communities.
Substance Abuse And Mental Health Services Adminis

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 813212
SLED
Grant a conditional waiver of fees in the amount of $69,000 for three in-lieu parking certificates for the property located at 224 and 226 Ocean Avenue in consi
Solicitation # NOE 224
The City of Laguna Beach has approved a conditional waiver of $69,000 in development fees for three in-lieu parking certificates associated with the properties at 224 and 226 Ocean Avenue, Laguna Beach, California, to support public benefits including increased business development, employment opportunities, and expansion of the city’s tax base. This waiver is contingent upon the property owner securing an effective coastal development permit for the parking certificates, serving as the sole condition for the fee relief. The action is legally justified under the California Environmental Quality Act (CEQA), specifically invoking the commonsense exemption under 14 CCR Section 15061(b)(3), which confirms no environmental impact is possible, and the existing facilities exemption under 14 CCR Section 15301, which applies to minor alterations to existing structures without expanding their use. The project involves an administrative decision rather than a competitive procurement, and no traditional contract line items, evaluation factors, or federal acquisition regulation clauses are applicable, as this is a local government environmental determination with no federal procurement components. The City of Laguna Beach, acting as the lead agency, provided the approval on October 28, 2025, with Louie Lacasella, Senior Management Analyst, serving as the primary point of contact for project oversight. There is no formal period of performance, delivery schedule, invoicing mechanism, or payment office details outlined, as the action is a one-time fee waiver tied directly to regulatory compliance. The place of performance is clearly defined as the subject properties at 224 and 226 Ocean Avenue, and no other attachments, representations, certifications, or special requirements beyond the coastal development permit condition are included.
City of Laguna Beach

POSTED

10 months ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
Engaging faith-based organizations to sustain lifesaving HIV and TB services in EthiopiaThe contract involves a funding opportunity from the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, aimed at engaging faith-based organizations in Ethiopia to sustain and enhance lifesaving HIV, tuberculosis (TB), and cervical cancer services. With an anticipated fiscal year funding of approximately $5 million (subject to availability), this initiative focuses on expanding access to comprehensive HIV services, including testing, prevention of vertical transmission, and both adult and pediatric care and treatment. The project targets key populations such as people at high risk for HIV, undiagnosed individuals living with HIV, those at risk of treatment interruption, pregnant and breastfeeding women, and individuals facing barriers to accessing conventional health services. Implementing cost-efficient, integrated service delivery models within the routine healthcare system is a core expectation, aiming to reach undiagnosed or treatment-defaulter populations and providing critical, lifesaving care for both HIV and TB. The initiative encourages country ownership by supporting country-led plans for greater program sustainability, and may also encompass efforts addressing other public health threats and emergencies in Ethiopia. The engagement of faith communities is fundamental to linking individuals to these essential health services, thereby promoting safer, healthier outcomes in vulnerable populations.
Centers For Disease Control-Ghc

POSTED

11 months ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541714
New
Grant
Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)The National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to provide continued support for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on conducting clinical trials to improve outcomes for patients experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings by identifying effective early-stage treatments. The program specifically seeks to establish a Clinical Coordinating Center (CCC) and a Data Coordinating Center (DCC) to support the network's infrastructure. While this notice serves as a forecast to allow potential applicants time to form collaborations and prepare responsive applications, formal solicitations are not currently being accepted.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 611430
New
Grant
Mentored Career Transition Award (KT1/R00)The Mentored Career Transition Award (KT1/R00), issued by the National Institutes of Health under the Department of Health and Human Services, is a biphasic grant designed to transition postdoctoral researchers into independent, tenure-track faculty roles. The award provides up to five years of total support, beginning with a mentored career development phase lasting one to two years. The second phase offers up to three years of independent research funding, which is contingent upon the recipient's satisfactory progress during the initial phase and the procurement of an approved, research-intensive faculty position. This forecasted opportunity is managed by the Division of Biomedical Research Workforce.
Professional and Management Development Training

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 621910
New
Grant
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment HubsThe National Institutes of Health, through the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute, is seeking to support the infrastructure for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). This initiative focuses on establishing clinical enrollment hubs to conduct trials aimed at improving outcomes for individuals experiencing non-stroke neurological and cardiovascular emergencies within pre-hospital or emergency department settings. This notice serves as a forecast to allow potential applicants time to establish collaborations and develop responsive applications. While the program aims to identify effective early-stage treatments, applications are not currently being solicited. Interested parties can contact the NINDS Department of Emergency Medicine for further information.
Ambulance Services

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Mentored Research Scientist Career Development Award (KR1)The Mentored Research Scientist Career Development Award (KR1), issued by the National Institutes of Health under the Department of Health and Human Services, is designed to support candidates with research doctoral degrees in their pursuit of future research independence. The award provides up to five years of protected time for intensive career development under the guidance of an experienced mentor. This opportunity is currently listed as a forecast with a posted date of August 13, 2026. Interested parties can contact the Division of Biomedical Research Workforce via email at nihtrain@mail.nih.gov for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Mentored Clinician Research Scientist Career Development Award (KC1)The Mentored Clinician Research Scientist Career Development Award (KC1) is a forecast opportunity provided by the National Institutes of Health under the Department of Health and Human Services. This award is designed to support clinician research scientists with clinical doctoral degrees, offering up to five years of protected time to undergo intensive research career development. The primary goal of the program is to prepare these candidates for future research independence through the guidance of an experienced mentor. Interested parties can contact the Division of Biomedical Research Workforce for further information. The award is listed as a forecast with a posted date of August 13, 2026, and detailed information can be accessed through the grants.gov portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 518210
Grant
Partnership with Common Fund Data Ecosystem ResourcesThe NIH Office of Strategic Coordination through its Common Fund is seeking partnerships between Common Fund data programs and external biomedical data resources to improve the reusability and integration of Common Fund datasets within broader scientific ecosystems. The initiative aims to advance the FAIR principles—Findable, Accessible, Interoperable, and Reusable—by fostering collaborations that bridge the Common Fund Data Ecosystem with other significant NIH data platforms such as the HEAL Data Ecosystem, BRAIN Initiative, Cancer Research Data Commons, ImmPort, TOPMed, and the Medical Imaging and Data Resource Center. These partnerships are intended to develop shared resources that enhance data connectivity, enable cross-platform analysis, and promote broader scientific utility of Common Fund data without supporting new clinical trials. The funding opportunity is open to non-CF biomedical data resources that can contribute infrastructure, tools, or expertise to amplify the impact of Common Fund datasets. Applicants must propose concrete plans for integration, interoperability, and sustainability of jointly developed resources. While no specific funding amount or deadline is indicated in the provided data, the solicitation was posted on August 6, 2026, and inquiries may be directed to the Common Fund Data Ecosystem Program via cfde@od.nih.gov. This effort reflects a strategic push by the NIH to unify diverse biomedical data ecosystems under common standards, enabling more comprehensive and efficient data-driven research across disciplines and institutions.
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Transformative Technologies for Experimental and Computational RNome Characterization and Functional AnalysisThe NIH Common Fund, in collaboration with other NIH Institutes and Centers, is preparing to issue a funding opportunity for the Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis initiative under the RNomics program. This initiative aims to develop high-risk, early-stage experimental and computational technologies that overcome major limitations in current RNA analysis methods, with a focus on sequencing RNA, detecting modifications, studying RNA function, and analyzing RNA across molecules, cells, and tissues. The program seeks innovations that have not yet been demonstrated at scale or in biologically relevant systems, prioritizing groundbreaking tools that can advance understanding of health and disease through integrated analysis of the entire RNome. This is a two-phase effort, where successful Phase 1 projects will be evaluated for transition to Phase 2, which is designed to deliver validated, widely usable tools for the scientific community. Applications are not currently being accepted; this notice serves as a forecast to allow potential applicants time to form collaborations and refine proposals. The initiative is part of a broader RNomics effort that includes technology enhancement centers, molecular standards, and a coordinating center, all aimed at establishing comprehensive RNA research capabilities. The funding opportunity will be administered by the National Institutes of Health under the Department of Health and Human Services, with a NAICS code of 541715 for research and development in the physical, engineering, and life sciences. All inquiries should be directed to the Common Fund RNomics Program at cfrnomics@od.nih.gov, and further details can be found through the grants.gov listing. The forecast notice was posted on August 5, 2026, with no set-aside designation or specific place of performance indicated.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
RNomics Technology Enhancement CentersThe NIH Common Fund, in collaboration with multiple NIH Institutes and Centers, is preparing to issue a funding opportunity for the RNomics program, specifically targeting the establishment of Technology Enhancement Centers (RTECs) aimed at advancing tools for comprehensive RNA analysis. These centers will build upon existing technologies with proven feasibility to improve methods for measuring, mapping, and testing RNA molecules across cells and tissues, with a focus on delivering practical, widely accessible enhancements. Key priorities include end-to-end RNA sequencing, quantitative mapping of RNA modifications, and integrated analysis of RNA sequence, structure, modification, interactions, localization, dynamics, and function, as well as the development of molecular and biochemical tools for RNA manipulation and functional validation. The RTECs are one component of the broader RNomics initiative, which also encompasses transformative technologies, molecular standards, and a coordinating center, all designed to enable a holistic understanding of the RNome and its role in health and disease. While applications are not currently being accepted, this forecast notice provides advance notice to help potential applicants form strong collaborations and refine project proposals. The opportunity is listed under NAICS code 541715, sponsored by the National Institutes of Health under the Department of Health and Human Services, with inquiries directed to the Common Fund RNomics Program at cfrnomics@od.nih.gov and further information available via the Grants.gov portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
RNomics Molecular StandardsThe NIH Common Fund, in collaboration with multiple NIH Institutes and Centers, is preparing to issue a funding opportunity for the RNomics Molecular Standards initiative, part of the broader RNomics program aimed at advancing the study of the complete RNA landscape in biological systems. This initiative will focus on developing, testing, refining, and distributing molecular reference standards for RNA modifications, including modified nucleosides and oligonucleotides, to ensure accurate, reproducible, and comparable results across diverse research platforms and laboratories. The standards will serve as benchmarks for evaluating RNA detection and analysis technologies and will be accompanied by guidance on their optimal selection and application, with plans in place for their sustained availability beyond the funding period. While applications are not currently being accepted, this forecast notice alerts the research community to an upcoming opportunity to engage in creating critical resources that will underpin the entire RNomics program. The standards developed under this initiative will support the broader goals of enhancing scientific rigor, facilitating cross-laboratory validation, and enabling the integration of multi-omic RNA data. The funding opportunity is administered by the National Institutes of Health under the Department of Health and Human Services, with inquiries directed to the Common Fund RNomics Program via cfrnomics@od.nih.gov and a North American Industry Classification System code of 541715. The posting date indicates this forecast is active as of August 5, 2026, and interested parties are encouraged to build collaborations and prepare proposals in advance of the formal solicitation.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 519290
Grant
RNomics Outreach and Coordination (ROC) CenterThe NIH Common Fund, in collaboration with other NIH Institutes and Centers, is preparing to launch the RNomics program to advance the study of the complete RNA landscape in biological systems, encompassing sequences, modifications, structures, locations, interactions, and functions. This initiative will foster the development of transformative tools and resources to enable integrated analysis of the RNome, with the goal of deepening understanding of human health and disease. The program will consist of four components: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center, though no applications are currently being accepted. This notice serves to inform potential applicants and encourage the formation of collaborations and robust research proposals ahead of future funding opportunities. The RNomics Outreach and Coordination (ROC) Center will act as the central hub for the consortium, responsible for data management, community engagement, and cross-project coordination. It will build and maintain a centralized data portal, establish and promote standardized data formats, coordinate the validation and benchmarking of RNA technologies, and lead large-scale data analyses across the program. The ROC Center will also drive outreach, training, and resource sharing initiatives to broaden adoption of RNomics tools and ensure the long-term accessibility and sustainability of all generated data assets. The National Institutes of Health, under the Department of Health and Human Services, is the issuing agency, with inquiries directed to the Common Fund RNomics Program via cfrnomics@od.nih.gov, and the forecasted posting date for the official solicitation is August 5, 2026.
Web Search Portals and All Other Information Services

POSTED

9 days ago

DEADLINE

N/A
View Details